30 October 2020 - - MedStar Washington Hospital Center in Washington, DC has treated its first COVID-19 patient with lenzilumab, US-based biopharmaceutical company Humanigen, Inc. (HGEN) said.
The primary goal of this Phase 3 random...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
30 October 2020 - - US-based Icosavax, Inc. has launched the company's COVID-19 vaccine program with preclinical data on the company's VLP vaccine candidate, IVX-411, which comprises a virus-like particle displaying the SARS-CoV-2 rece...
30 October 2020 - - Canada-based biopharmaceutical company Appili Therapeutics Inc. (TSX: APLI) (OTCQX: APLIF) has signed a collaboration, development and supply agreement with India-based Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDD...
30 October 2020 - Blue Water Vaccines Inc, a biopharmaceutical company, is accelerating the development of a new vaccine candidate to combat the potential pandemic influenza strain, G4 EA H1N1, that was identified by scientists in China in the summer...
30 October 2020 - Protagonist Therapeutics Inc (NASDAQ:PTGX), a clinical stage biopharmaceutical company, is advancing towards the clinical development of two additional oral peptide IL-23 receptor antagonist candidates developed as result of collabo...
30 October 2020 - Rafael Holdings, Inc, (NYSE: RFL), a company focused on the development of novel cancer therapies, has reported its financial results for the fourth quarter and fiscal year ended 31 July 2020, it was reported on Thursday.The company...
30 October 2020 - - Japanese pharmaceutical company Otsuka Pharmaceutical Co., Ltd's US-based Astex Pharmaceuticals, Inc subsidiary has entered into a Cooperative Research and Development Agreement with the US National Cancer Institute, part of ...